Avexa Limited
Avexa discovers drugs to treat vexing ailments. The pharmaceutical and research company works on the discovery and development of drugs for the treatment of infectious diseases, specifically HIV and antibiotic-resistant strains of bacteria. Avexa has worked on collaborative projects with Victorian College of Pharmacy, The Shanghai Institute of Organic Chemistry, North Carolina State University, and Georgetown University, among other institutions. The company was formed in 2004 when it was spun off from Australian drug discovery and biotechnology development company Amrad. Plans to merge with drugmaker Progen Pharmaceutical were canceled in 2009.
Contact Details
Office Address
Avexa Limited
576 Swan Street
Richmond, Victoria, Australia 3121
Phone: +61-3-9208-4300
Fax: +61-3-9208-4004
Executives
CEO and Director
Julian Chick
CFO and Secretary
Stephen Kerr